Prevalence, patterns of disease and outcome in patients with systemic lupus erythematosus who develop severe haematological problems
- PMID: 12595615
- DOI: 10.1093/rheumatology/keg069
Prevalence, patterns of disease and outcome in patients with systemic lupus erythematosus who develop severe haematological problems
Abstract
Objective: To evaluate the prevalence of major haemolytic disease-severe autoimmune haemolytic anaemia and severe thrombocytopenia-and to assess when these features develop. We also sought to analyse the clinical and serological outcomes of patients with haemolytic anaemia and thrombocytopenia with systemic lupus erythematosus (SLE) as compared with patients without these cytopenias.
Methods: We reviewed retrospectively all the available case notes from our lupus cohort of 305 patients followed up between 1978 and 2000 (mean follow-up 7 yr). We identified 30 patients with SLE (9.8%), of whom 20 (6.6%) had severe haemolytic anaemia and 10 (3.3%) had severe thrombocytopenia. Each patient was matched for age, sex and ethnicity with two control patients.
Results: We recorded a total of 42 episodes of severe haematological events: four patients had a second haemolytic episode and eight patients had a second thrombocytopenic episode. Five patients had both thrombocytopenia and haemolytic anaemia. One per cent of patients had severe haemolytic anaemia prior to the diagnosis of SLE and 2.5% of patients presented with these haematological disorders. Haemolytic anaemia and thrombocytopenia were associated with renal involvement (0.01>P>0.001) and anticardiolipin antibodies (ACL) (0.01>P>0.001), but not anti-dsDNA antibodies. Calculation of the BILAG index at the time of severe haematological crisis demonstrated that renal, central nervous system involvement and general symptoms are more frequently present. Forty-one per cent of patients were already on either prednisolone (<10 mg) or an immunosuppressive agent at the onset of the event.
Conclusion: Our data demonstrate that both haemolytic anaemia and thrombocytopenia are associated with ACL but not anti-dsDNA antibodies. When faced with a patient with a severe haematological manifestation of lupus, active disease in other organs is likely to be present.
Similar articles
-
Significance of autoimmune haemolytic anaemia and immune thrombocytopenia (Evans' syndrome) in systemic lupus erythematosus.Malays J Pathol. 1994 Jun;16(1):79-82. Malays J Pathol. 1994. PMID: 16329581
-
Severe haematological involvement in children with systemic lupus erythematosus and clinical associations.Rheumatology (Oxford). 2025 Apr 1;64(4):2153-2161. doi: 10.1093/rheumatology/keae414. Rheumatology (Oxford). 2025. PMID: 39093021
-
Haemolytic anaemia in a multi-ethnic cohort of lupus patients: a clinical and serological perspective.Lupus. 2008 Aug;17(8):739-43. doi: 10.1177/0961203308090990. Lupus. 2008. PMID: 18625652 Free PMC article.
-
Anaemia in systemic lupus erythematosus: from pathophysiology to clinical assessment.Ann Rheum Dis. 2006 Feb;65(2):144-8. doi: 10.1136/ard.2005.041673. Epub 2005 Aug 3. Ann Rheum Dis. 2006. PMID: 16079164 Free PMC article. Review.
-
Autoimmune haemolytic anaemia and autoimmune thrombocytopenia in childhood-onset systemic lupus erythematosus: updates on pathogenesis and treatment.Curr Opin Rheumatol. 2018 Sep;30(5):498-505. doi: 10.1097/BOR.0000000000000523. Curr Opin Rheumatol. 2018. PMID: 29979258 Review.
Cited by
-
An unusual association between anti-histone antibody seropositive SLE, autoimmune hemolytic anemia, and herpetic rash: A case report.J Family Med Prim Care. 2022 Apr;11(4):1542-1544. doi: 10.4103/jfmpc.jfmpc_1324_21. Epub 2022 Mar 18. J Family Med Prim Care. 2022. PMID: 35516673 Free PMC article.
-
Chinese SLE Treatment and Research group (CSTAR) registry: Clinical significance of thrombocytopenia in Chinese patients with systemic lupus erythematosus.PLoS One. 2019 Nov 20;14(11):e0225516. doi: 10.1371/journal.pone.0225516. eCollection 2019. PLoS One. 2019. PMID: 31747435 Free PMC article.
-
[Rheumatic and hemato-/oncological disorders].Z Rheumatol. 2005 Feb;64(1):3-11. doi: 10.1007/s00393-005-0698-4. Z Rheumatol. 2005. PMID: 15756494 Review. German.
-
Clinicopathological Characteristics and Outcomes of Lupus Nephritis Patients With Thrombocytopenia: A Single-Center Retrospective Study.Immun Inflamm Dis. 2025 Mar;13(3):e70179. doi: 10.1002/iid3.70179. Immun Inflamm Dis. 2025. PMID: 40105598 Free PMC article.
-
Prevalence of the American College of Rheumatology hematological classification criteria and associations with serological and clinical variables in 460 systemic lupus erythematosus patients.Rev Bras Hematol Hemoter. 2015 Mar-Apr;37(2):115-9. doi: 10.1016/j.bjhh.2015.01.006. Epub 2015 Jan 31. Rev Bras Hematol Hemoter. 2015. PMID: 25818822 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical